Source: PR Newswire

Press Release: Accuron Technologies : Accuron MedTech Announces Divestment of Shares in Veredus Laboratories to SEKISUI CHEMICAL

SINGAPORE, April 3, 2018 /PRNewswire/ -- Accuron MedTech Group (Accuron MedTech), Southeast Asia's largest medical device company, today announced the completion of the divestment of its shares in Veredus Laboratories (Veredus) to SEKISUI CHEMICAL CO.,LTD, a Japanese public company and own...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
10-50K
Tan Kai Hoe's photo - President & CEO of Accuron

President & CEO

Tan Kai Hoe

CEO Approval Rating

74/100

Read more